US Patent 8008003 Gene expression profiling of EGFR positive cancer
Patent 8008003 was granted and assigned to Genomic Health on August, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8008003 Gene expression profiling of EGFR positive cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
